Debate. Cerebral embolic protection systems in TAVI: there is some supportive evidence

P. Jiménez Quevedo
{"title":"Debate. Cerebral embolic protection systems in TAVI: there is some supportive evidence","authors":"P. Jiménez Quevedo","doi":"10.24875/recice.m23000374","DOIUrl":null,"url":null,"abstract":"Answer: Former studies described that, during TAVI, loose debris like arterial wall fragments, thrombi, valve tissue, and foreign bodies often enters the circulation.1 These particles are the aftermath of the device making its way through the aorta towards the aortic annulus, the positioning and displacement of a calcified stenotic valve between the new valve stent and the aortic wall, and further manipulations to optimize results (postdilatation). To this date, numerous studies have been published on the safety and efficacy profile of these cerebral protection devices (CPD). Specifically, 4 randomized clinical trials have been published associated with the SENTINEL (Boston Scientific Corp., United States): MISTRAL-C,2 CLEAN TAVI,3 SENTINEL,4 and PROTECTED TAVR5 we can talk about later on. The MISTRAL-C trial used cerebral magnetic resonance imaging to demonstrate a significant reduction in the number of patients with multiple cerebral lesions (20% vs 0%; P = .03) and less cognitive impairment (4% vs 27%; P = .017). Similarly, the CLEAN TAVI trial also reported fewer novel lesions and of a smaller volume without any differences being reported in the number of clinical events in the group that used CPD. These studies demonstrated fragments being captured in almost in 100% of the cases. Several metanalyses6-13 also confirm these results regarding the number and volume of cerebral lesions described, and even some show lower rates of strokes in the DPC group.10,12,13 Therefore, we not only have the visual in situ demonstration of the particles being captured in the baskets following implantation, but also scientific evidence that CPD are effective capturing fragments released during TAVI that can land in cerebral circulation, thus lowering the number of cerebral lesions found on the magnetic resonance imaging during the procedure. However, whether capturing such particles with the device has a clear clinical benefit for its widespread use is still to be elucidated.","PeriodicalId":34613,"journal":{"name":"REC Interventional Cardiology English Ed","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"REC Interventional Cardiology English Ed","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24875/recice.m23000374","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Answer: Former studies described that, during TAVI, loose debris like arterial wall fragments, thrombi, valve tissue, and foreign bodies often enters the circulation.1 These particles are the aftermath of the device making its way through the aorta towards the aortic annulus, the positioning and displacement of a calcified stenotic valve between the new valve stent and the aortic wall, and further manipulations to optimize results (postdilatation). To this date, numerous studies have been published on the safety and efficacy profile of these cerebral protection devices (CPD). Specifically, 4 randomized clinical trials have been published associated with the SENTINEL (Boston Scientific Corp., United States): MISTRAL-C,2 CLEAN TAVI,3 SENTINEL,4 and PROTECTED TAVR5 we can talk about later on. The MISTRAL-C trial used cerebral magnetic resonance imaging to demonstrate a significant reduction in the number of patients with multiple cerebral lesions (20% vs 0%; P = .03) and less cognitive impairment (4% vs 27%; P = .017). Similarly, the CLEAN TAVI trial also reported fewer novel lesions and of a smaller volume without any differences being reported in the number of clinical events in the group that used CPD. These studies demonstrated fragments being captured in almost in 100% of the cases. Several metanalyses6-13 also confirm these results regarding the number and volume of cerebral lesions described, and even some show lower rates of strokes in the DPC group.10,12,13 Therefore, we not only have the visual in situ demonstration of the particles being captured in the baskets following implantation, but also scientific evidence that CPD are effective capturing fragments released during TAVI that can land in cerebral circulation, thus lowering the number of cerebral lesions found on the magnetic resonance imaging during the procedure. However, whether capturing such particles with the device has a clear clinical benefit for its widespread use is still to be elucidated.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
辩论TAVI的脑栓塞保护系统:有一些支持性证据
答:以前的研究表明,在TAVI过程中,动脉壁碎片、血栓、瓣膜组织和异物等松散碎片经常进入循环。1这些颗粒是装置穿过主动脉进入主动脉环、钙化狭窄瓣膜在新瓣膜支架和主动脉壁之间定位和移位的结果,以及进一步操作以优化结果(扩张后)。到目前为止,已经发表了许多关于这些大脑保护装置(CPD)的安全性和有效性的研究。具体而言,已经发表了4项与SENTINEL(美国波士顿科学公司)相关的随机临床试验:MISTRAL-C、2个CLEAN TAVI、3个SENTINEL、4和PROTECTED TAVR5,我们稍后可以讨论。MISTRAL-C试验使用脑磁共振成像显示,多发性脑损伤患者数量显著减少(20%对0%;P=0.03),认知障碍较少(4%对27%;P=0.017)。同样,CLEAN TAVI试验也报告了较少的新病变和较小的体积,在使用CPD的组中没有任何临床事件数量的差异。这些研究表明,在几乎100%的病例中,碎片被捕获。一些荟萃分析6-13也证实了这些关于所描述的脑损伤的数量和体积的结果,甚至一些结果显示DPC组的中风率较低。10,12,13因此,我们不仅可以直观地原位演示植入后篮子中捕获的颗粒,而且还有科学证据表明,CPD是有效捕获TAVI过程中释放的碎片,这些碎片可以降落在大脑循环中,从而降低手术过程中磁共振成像中发现的脑损伤数量。然而,用该设备捕获此类颗粒是否具有广泛使用的明显临床益处仍有待阐明。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
REC Interventional Cardiology English Ed
REC Interventional Cardiology English Ed Medicine-Cardiology and Cardiovascular Medicine
CiteScore
3.70
自引率
0.00%
发文量
86
审稿时长
15 weeks
期刊最新文献
Impella-Clip: a secure and effective strategy in cardiogenic shock due to acute severe mitral regurgitation. Case resolution New TAVI technique for difficult valve crossing Marking a milestone. REC: Interventional Cardiology assigned its first impact factor Cardiac catheterization activity in pediatric cardiac transplantation. Can catheterization needs be predicted? The PULSTA valve in native right ventricular outflow tract: initial experience in 3 Spanish hospitals
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1